What is the treatment for a patient with a chalazion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chalazion

Initial Conservative Management (First 4-6 Weeks)

Start all chalazia with warm compresses (5-10 minutes, 3-4 times daily) combined with eyelid hygiene, as this is the recommended first-line approach. 1, 2

  • Apply warm compresses to the affected eyelid for 5-10 minutes, 3-4 times daily to promote drainage of the obstructed meibomian gland 1, 2
  • Perform gentle massage of the affected area immediately after warm compresses to help express the obstructed gland 3, 2
  • Clean eyelid margins with mild soap or commercial eyelid cleansers as part of regular eyelid hygiene 3, 2
  • Treat any underlying bacterial blepharitis or meibomian gland dysfunction before addressing the chalazion itself, as these are common predisposing factors 3, 2

Conservative Treatment Success Rate

  • Conservative management resolves approximately 29-33% of chalazia within 3 months 4
  • Most chalazia that will respond to conservative therapy do so within 4-6 weeks 2

Treatment Escalation for Persistent Chalazia

If the chalazion persists after 4-6 weeks of conservative therapy, proceed to intralesional steroid injection before considering surgery. 2

Intralesional Steroid Injection

  • Inject triamcinolone acetonide (10 mg/mL, 0.3 mL) directly into the lesion via the percutaneous route 2, 5
  • This approach achieves a 93.8% success rate compared to 58.3% with conservative management alone 5
  • Re-evaluate within a few weeks after injection to assess response and check intraocular pressure 2
  • Common pitfall: One case report documented hypopigmentary skin changes at the injection site, particularly in patients with multiple chalazia 5

Surgical Incision and Curettage

  • Reserve surgery for chalazia that fail both conservative management and steroid injection 2
  • Perform transconjunctival incision and drainage with curettage 6
  • Surgical treatment successfully resolves approximately 72-74% of selected chalazia 6, 4
  • Thermal cautery after surgery does not impact recurrence rates (78% vs 74% no recurrence at 6 months) and should be left to practitioner discretion 6

Critical Red Flags Requiring Biopsy

Always biopsy chalazia with any of the following features to exclude sebaceous carcinoma, which can masquerade as recurrent chalazia, especially in elderly patients: 7, 3, 2

  • Recurrence in the same location, particularly in elderly patients 7, 3, 2
  • Marked asymmetry or resistance to standard therapy 3, 2
  • Unifocal recurrent chalazia unresponsive to therapy 3, 2
  • Atypical features including eyelid margin distortion, focal lash loss, or ulceration 3, 2
  • Unilateral chronic blepharitis unresponsive to therapy 3, 2
  • History of multiple chalazion excisions at the same site 1

Do not continue conservative management beyond 4-6 weeks without reassessment, as this delays diagnosis of potential malignancy. 3, 2

Management of Underlying Conditions

Evaluate and Treat Predisposing Factors

  • Assess for meibomian gland dysfunction, rosacea, or seborrheic dermatitis in patients with recurrent chalazia 1, 2
  • Institute regular eyelid hygiene for patients with blepharitis or meibomian gland dysfunction 1, 2
  • Consider systemic antibiotics for severe underlying blepharitis 2
  • Emerging evidence: One case report suggests subclinical hypothyroidism may predispose to recurrent chalazia, with remission occurring after levothyroxine treatment 8

Emerging Non-Surgical Options for Recurrent Chalazia

  • Intense pulsed light (IPL) with meibomian gland expression shows promise as a non-surgical option for recurrent multiple chalazia resistant to conventional therapy 7, 2
  • IPL has demonstrated high Demodex eradication rates and improved meibum quality compared to topical treatments 7
  • Caution: Use IPL with caution in darkly pigmented individuals (above Fitzpatrick skin type IV) due to risk of burns and pigmentation changes 7
  • Vectored thermal pulsation therapy may improve meibomian gland function 2

Special Pediatric Considerations

  • Children with chalazia should be evaluated by an ophthalmologist for chronic blepharokeratoconjunctivitis, which is often unrecognized and may present with recurrent conjunctivitis, keratitis, neovascularization, and eyelid inflammation 1, 2
  • Refer to ophthalmology if there is visual loss, moderate/severe pain, or severe/chronic redness 2

Prevention Strategies

  • Maintain regular eyelid hygiene for patients prone to recurrent chalazia, especially those with blepharitis or meibomian gland dysfunction 3, 2
  • Treat underlying skin conditions such as rosacea or seborrheic dermatitis 3, 2
  • Avoid eye makeup during active inflammation 3, 2

References

Guideline

Chalazion and Hordeolum Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chalazion Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chalazion and Hordeolum Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Thermal cautery after chalazion surgery and its effect on recurrence rates.

Optometry and vision science : official publication of the American Academy of Optometry, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.